SFX by Ex Libris Inc.

Title:	Transcriptional repression mediated by the WT1 Wilms tumor gene product
Source:	Science [0036-8075] Madden, S L yr:1991

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	BUCKLER, A J J. "ISOLATION CHARACTERIZATION AND EXPRESSION OF THE MURINE WILMS' TUMOR GENE WT1 DURING KIDNEY DEVELOPMENT." Molecular and cellular biology 11.3 (1991): 1707-1712.
description	2.	Westcott, M C. "Response time prolongation for a motion stimulus in patients with glaucoma and its relationship with elevation of the motion threshold." Journal of glaucoma 9.4 (2000): 289-295.
description	3.	Lee, S B B. "Wilms tumor and the WT1 gene." Experimental cell research 264.1 (2001): 74-99.
description	4.	Loeb, David M M. "The role of the Wilms tumour gene (WT1) in normal and malignant haematopoiesis." Expert reviews in molecular medicine 9.14 (2007): 1-17.
description	5.	Larsson, S H H. "Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing." Cell 81.3 (1995): 391-401.
description	6.	Rauscher, F.J. I. "The WT1 Wilms tumor gene product: A developmentally regulated transcription factor in the kidney that functions as a tumor suppressor." The FASEB journal 7.10 (1993): 896-903.
description	7.	Hastie, N D D. "Life, sex, and WT1 isoforms--three amino acids can make all the difference." Cell 106.4 (2001): 391-4.
description	8.	Rauscher, F J J. "Binding of the Wilms' tumor locus zinc finger protein to the EGR-1 consensus sequence." Science 250.4985 (1990): 1259-62.
description	9.	Haber, D A A. "Alternative splicing and genomic structure of the Wilms tumor gene WT1." Proceedings of the National Academy of Sciences of the United States of America 88.21 (1991): 9618-22.
description	10.	Loeb, David M M. "The role of WT1 in oncogenesis: tumor suppressor or oncogene?" International journal of hematology 76.2 (2002): 117-26.
description	11.	Nikolova, G. "Sequence variant in the laminin gamma1 (LAMC1) gene associated with familial pelvic organ prolapse." Human genetics 120.6 (2007): 847-56.
description	12.	Wall, M. "The psychometric function and reaction times of automated perimetry in normal and abnormal areas of the visual field in patients with glaucoma." Investigative ophthalmology & visual science 37.5 (1996): 878-885.
description	13.	Allison, J. "Geant4 developments and applications." IEEE transactions on nuclear science 53.1 (2006): 270-278.
description	14.	Armstrong, J F F. "The expression of the Wilms' tumour gene, WT1, in the developing mammalian embryo." Mechanisms of development 40.1-2 (1992): 85-97.
description	15.	Negus, K. "(D1S3309E), a novel target binding site for the Wilms' tumour suppressor 1 (WT1) gene, maps to human chromosome 1q21-->22." Cytogenetics and cell genetics 72.4 (1996): 306-9.
description	16.	Hirose, M. "The role of Wilms' tumor genes." The journal of medical investigation 46.3-4 (1999): 130-40.
description	17.	Svensson, E. "Deregulation of the Wilms' tumour gene 1 protein (WT1) by BCR/ABL1 mediates resistance to imatinib in human leukaemia cells." Leukemia 21.12 (2008): 2485-94.
description	18.	Kreidberg, J A A. "WT-1 is required for early kidney development." Cell 74.4 (1993): 679-91.
description	19.	Burwell, D M A. "Isoforms of Wilms' tumor suppressor gene (WT1) have distinct effects on mammary epithelial cells." Oncogene 26.23 (2007): 3423-30.
description	20.	Kedersha, N. "Stress granules: the Tao of RNA triage." Trends in biochemical sciences 33.3 (2008): 141-150.